First in India to make Spheroids for Non-alcoholic steatohepatitis (NASH)

First in India to make in vitro Spheroids platform towards solving the COVID-19 puzzle

Vision

To innovate in research and development and make personalized treatment a reality.

Mission

To utilize the current state of the art technologies in spheroid and Patient-Derived Xenograft platforms and use them as tools for new treatment strategies.

Spheroid Cell Culture to create Disease-in-a-Dish Model

Each spheroid platform is microfabricated to represent a particular disease associated with a specific organ or tissue. We at OncoSeek Bio create such highly complex tissues to enable innovation in finding cures. Our spheroid platforms should help the researchers in therapeutic, diagnostic and vaccine research.

Patient-Derived Xenograft Platforms in Mouse

Our fully characterized patient-derived xenograft platform aims to offer superior pre-clinical translational research services for predicting the clinical success of newer cancer therapeutics in discovery. Also, we aim to advance clinical development and identify personalized cancer therapeutics for various various cancers.

Repurposing of drugs for Cancer Therapy

Our personalized in vitro and in vivo models of patient-derived fresh tumor samples aim to offer collaborative cancer research towards the re-purposing of drugs for effective cancer therapy.

Patient Tumor and iPSCs Derived Organoid /Spheroid Platforms for screening drugs for Personalized Cancer Treatment

We can screen drugs and their combinations on Patient Primary Tumor Derived Organoids/Spheroids towards making Cancer Treatment more Personalized. Our models will help the oncologist with relevant real-time response data of his/her patients' primary tumor to the drug/combination of his choice and thereby identifying the best regimen for the patient even before the start of chemotherapy.

Solving the unmet needs in the drug discovery of many other diseases

Using our organoid models for various other diseases, we aim to offer superior pre-clinical translational research services to speed up the drug discovery process.